• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medication during pregnancy and nursing is a challenge for women suffering from the condition. There is a lack of information about how long-term exposure to these drugs can affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological disorders such as hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications need to balance the advantages of taking them against the potential risks to the foetus. Physicians don't have the information needed to make unequivocal recommendations but they can provide information on the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy were not at higher risk of fetal malformations or structural birth defects. Researchers conducted a large population-based case control study to examine the prevalence of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to make sure that the classification was correct and to minimize any bias.

However, the study had its limitations. Researchers were unable in the beginning, to separate the effects caused by the medication from the disorder. This makes it difficult for researchers to determine if the small differences observed between the groups exposed were due to medication use or caused by comorbidities. Additionally the study did not study the long-term outcomes of offspring.

The study showed that babies whose mothers took ADHD medication during pregnancy had a slightly higher risk of admission to the neonatal care unit (NICU), compared to mothers who didn't take any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. This increase was due to central nervous system-related disorders and the increased risk of admission was not found to be influenced by the stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy were also at an elevated chance of having a caesarean birth or having a child with a low Apgar score (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy may be offset by the higher benefit to both the mother and child of continuing treatment for the woman's disorder. Physicians should talk to their patients about this and try to help them develop coping with adhd Without medication (http://bridgehome.cn) strategies that can lessen the impact of her disorder in her daily functioning and her relationships.

Medication Interactions

Many doctors are confronted with the dilemma of whether to keep treatment or stop as more women are diagnosed with ADHD. These decisions are often taken without clear and authoritative evidence. Instead, physicians must consider their own expertise in conjunction with the experiences of other physicians and the research on the topic.

The issue of risk to the infant can be difficult to determine. A lot of studies on this issue are based on observational data rather than controlled research and their findings are often contradictory. Most studies focus on live births, which may underestimate the severity of teratogenic effects that can lead to abortions or terminations of pregnancy. The study presented in this journal club addresses these limitations by looking at data from both live and deceased births.

The conclusion The conclusion: While some studies have found an association between adhd treatment medication medications and the possibility of certain birth defects, other studies have found no such relationship, and most studies have a neutral or slightly negative impact. In each case, a careful analysis of the risks and benefits is required.

For many women with ADHD, the decision to stop taking medication can be difficult, if not impossible. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of being isolated. A loss of medication may also impact the ability to safely drive and complete work-related tasks, which are essential aspects of daily life for those suffering from ADHD.

She suggests that women who are unsure whether to continue taking medication or discontinue it due to pregnancy, educate their family members, colleagues, and their friends about the condition, the effects on daily functioning, and the benefits of keeping the current treatment. It can also help women feel more confident in her decision. Certain medications can pass through the placenta. If a woman decides not to take her ADHD medication while breastfeeding, it is important to be aware that the drug could be passed on to her baby.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (get adhd medication online) increases as do concerns about what adhd medications are there uk impact the drugs could have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Researchers utilized two massive data sets to study more than 4.3 million pregnancies and determine if the use of stimulant medications caused birth defects. Although the risk overall remains low, the scientists found that exposure in the first trimester to ADHD medications was linked to a slightly higher rate of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study found no link between the use of early medications and congenital abnormalities such as facial clefting or club foot. The results are in line with previous studies showing the presence of a small, but significant increase in the risk of developing cardiac malformations among women who started taking ADHD medications prior to the birth of their child. This risk increased during the latter half of pregnancy, when a lot of women stopped taking their medication.

Women who took ADHD medications in the first trimester of their pregnancy were also more likely to have a caesarean section, a low Apgar score following delivery, and a baby who needed help breathing at birth. However the authors of the study were not able to eliminate bias due to selection by limiting the study to women who didn't have any other medical issues that could have contributed to these findings.

The researchers hope that their research will help inform the clinical decisions of doctors who treat pregnant women. The researchers recommend that while discussing risks and benefits are important, the decision regarding whether or not to stop medication should be based on the severity of each woman's ADHD symptoms and her requirements.

The authors also caution that even though stopping the medication is an alternative, it is not an option to consider due to the high prevalence of depression and other mental health issues in women who are pregnant or post-partum. Further, research shows that women who stop taking their medications will have a difficult time adjusting to a life without them after the baby is born.

Nursing

It can be a stressful experience to become a mom. Women with ADHD who have to manage their symptoms while attending physician appointments, getting ready for the arrival of their child and adapting to new routines in the home are often faced with a number of difficulties. Many women choose to continue taking their ADHD medication during pregnancy.

The risk for nursing infant is low because the majority of stimulant medication is absorbed through breast milk at a low level. However, the rate of exposure to medication by the newborn can vary depending on dosage, frequency it is administered, and the time of the day the medication is administered. In addition, individual medications enter the baby's system differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn infant is not yet fully known.

Because of the lack of research, some physicians might be tempted to stop taking stimulant drugs during a woman's pregnancy. It is a difficult decision for the mother, who must weigh the benefits of continuing her medication against the risks to the foetus. In the meantime, until more information is available, GPs may ask pregnant patients whether they have a background of ADHD or if they intend to take medication in the perinatal phase.

Numerous studies have proven that women can continue to take their ADHD medication safely during pregnancy and while breast-feeding. As a result, many patients are choosing to do so and, in consultation with their doctor they have found that the benefits of maintaining their current medication exceed any risk.

It is crucial for women suffering from ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation should also be offered to help pregnant people with ADHD be aware of their symptoms and the root cause Learn about the available treatment options and strengthen existing strategies for managing. This should be a multidisciplinary approach including obstetricians, GPs and psychiatrists. Pregnancy counselling should include discussion of a management plan for both mother and child, and monitoring for signs of deterioration, and when necessary, making adjustments to the medication regimen.